{
    "Trade/Device Name(s)": [
        "B\u00b7R\u00b7A\u00b7H\u00b7M\u00b7S PCT sensitive KRYPTOR\u00ae Test System"
    ],
    "Submitter Information": "B\u00b7R\u00b7A\u00b7H\u00b7M\u00b7S Aktiengesellschaft",
    "510(k) Number": "K070310",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040887"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NTM"
    ],
    "Summary Letter Date": "March 31, 2008",
    "Summary Letter Received Date": "February 20, 2008",
    "Submission Date": "February 20, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.3210"
    ],
    "Regulation Name(s)": [
        "Antigen, Inflammatory Response Marker, Sepsis"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "immunology"
    ],
    "Analyte(s)": [
        "Procalcitonin (PCT)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube",
        "Glass tube",
        "Plastic tube"
    ],
    "Instrument(s)/Platform(s)": [
        "B\u00b7R\u00b7A\u00b7H\u00b7M\u00b7S KRYPTOR\u00ae analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunofluorescent assay",
        "Time-Resolved Amplified Cryptate Emission (TRACE)"
    ],
    "Methodologies": [
        "Homogeneous sandwich immunoassay",
        "Immunofluorescence"
    ],
    "Submission Type(s)": [
        "Assay",
        "Automated system",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for B\u00b7R\u00b7A\u00b7H\u00b7M\u00b7S PCT sensitive KRYPTOR\u00ae immunofluorescent assay for automated detection of procalcitonin in serum and plasma using TRACE technology",
    "Indications for Use Summary": "Used in conjunction with other laboratory findings and clinical assessment to aid risk assessment of critically ill ICU patients on first day of admission for progression to severe sepsis and septic shock by quantifying procalcitonin in serum or plasma",
    "fda_folder": "Microbiology"
}